Objective: To evaluate the long-term results and operative experience of distal splenocaval shunt.
Method: 66 patients with portal hypertension were treated by distal spleno-caval shunt. Of these patients 57 were males and 9 females with a mean age of 39 years. All the patients were followed up.
Result: The operative mortality rate was 7.58%. Only 5 patients experienced recurrent bleeding (7.58%). None of the patients had clinical hepatic encephalopathy. Five-year survival rate was 70.45%.
Conclusion: Distal splenocaval shunt is suitable for portal hypertension patients with hepatopetal portal flow.